Replies to post #633698 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

UCLA has already advanced DC vaccine technology beyond DCVax-L. DCVax-L is a 20 year old discover and every additional improvement makes for a better vaccine and a uniquely patentable treatment that NWBO doesn't own. UCLA and Mayo Clinic both have their own dendritic cell vaccines in clinical trials that are NOT DCVax-L. They both are manufacturing a custom formulation of their own. NWBO has no rights to the results of the NIH/UCLA SPORE Combo trial.